Founded in 2019, Jurata Thin Film, Inc. is a privately held biotechnology company working to revolutionize the way vaccines and biologics are stored, distributed and delivered to all who need them around the world. Jurata’s thin film technology is manufactured without lyophilization and can be stored at room temperature for up to three years prior to reconstitution and for up eight months after reconstitution while maintaining therapeutic payload potency. This technology has also been proven to protect its cargo even when exposed to extreme temperatures, as is often the case during shipping and distribution. This technology could remove the need for cold chain logistics in vaccine and biologic transport and storage, making cutting edge therapies accessible to everyone who needs them around the world.